These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 8531887)

  • 1. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.
    AlonsoDeVelasco E; Verheul AF; Verhoef J; Snippe H
    Microbiol Rev; 1995 Dec; 59(4):591-603. PubMed ID: 8531887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains.
    Chimalapati S; Cohen J; Camberlein E; Durmort C; Baxendale H; de Vogel C; van Belkum A; Brown JS
    Infect Immun; 2011 Dec; 79(12):4965-76. PubMed ID: 21947774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.
    Briles DE; Hollingshead SK; Nabors GS; Paton JC; Brooks-Walter A
    Vaccine; 2000 Dec; 19 Suppl 1():S87-95. PubMed ID: 11163470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of putative pneumococcal virulence proteins.
    Paton JC; Berry AM; Lock RA
    Microb Drug Resist; 1997; 3(1):1-10. PubMed ID: 9109091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal Infections and Invasive Potential of Nonencapsulated
    Bradshaw JL; Pipkins HR; Keller LE; Pendarvis JK; McDaniel LS
    mBio; 2018 Jan; 9(1):. PubMed ID: 29339428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to Streptococcus pneumoniae: Factors affecting production and efficacy.
    Casal J; Tarragó D
    Curr Opin Infect Dis; 2003 Jun; 16(3):219-24. PubMed ID: 12821811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media.
    Keller LE; Bradshaw JL; Pipkins H; McDaniel LS
    Front Cell Infect Microbiol; 2016; 6():55. PubMed ID: 27242973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of host defense against infection with Streptococcus pneumoniae.
    Bruyn GA; Zegers BJ; van Furth R
    Clin Infect Dis; 1992 Jan; 14(1):251-62. PubMed ID: 1571441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyamine transporter potABCD is required for virulence of encapsulated but not nonencapsulated Streptococcus pneumoniae.
    Pipkins HR; Bradshaw JL; Keller LE; Swiatlo E; McDaniel LS
    PLoS One; 2017; 12(6):e0179159. PubMed ID: 28586394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal virulence factors and host immune responses to them.
    Watson DA; Musher DM; Verhoef J
    Eur J Clin Microbiol Infect Dis; 1995 Jun; 14(6):479-90. PubMed ID: 7588820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of Streptococcus pneumoniae in children living in southwest China and assessment of a potential protein vaccine, rPfbA.
    Yan Z; Cui Y; Zhou W; Li W; Tan X; Chen W; Zhang J; Jiang Y
    Vaccine; 2019 Jan; 37(5):721-731. PubMed ID: 30611601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proteins of Streptococcus pneumoniae: perspectives for development of pneumococcal vaccine].
    Vorob'ev DS; Semenova IB; Kurbatova EA
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (6):98-104. PubMed ID: 21384595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The virulence function of Streptococcus pneumoniae surface protein A involves inhibition of complement activation and impairment of complement receptor-mediated protection.
    Ren B; McCrory MA; Pass C; Bullard DC; Ballantyne CM; Xu Y; Briles DE; Szalai AJ
    J Immunol; 2004 Dec; 173(12):7506-12. PubMed ID: 15585877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates from Colombian children.
    Vela Coral MC; Fonseca N; Castañeda E; Di Fabio JL; Hollingshead SK; Briles DE
    Emerg Infect Dis; 2001; 7(5):832-6. PubMed ID: 11747695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
    Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptococcus pneumoniae in biofilms are unable to cause invasive disease due to altered virulence determinant production.
    Sanchez CJ; Kumar N; Lizcano A; Shivshankar P; Dunning Hotopp JC; Jorgensen JH; Tettelin H; Orihuela CJ
    PLoS One; 2011; 6(12):e28738. PubMed ID: 22174882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Virulence of an Encapsulated Streptococcus pneumoniae Upon Expression of Pneumococcal Surface Protein K.
    Pipkins HR; Bradshaw JL; Keller LE; McDaniel LS
    J Infect Dis; 2018 Apr; 217(10):1637-1644. PubMed ID: 29394357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.
    O'Brien KL; Steinhoff MC; Edwards K; Keyserling H; Thoms ML; Madore D
    Pediatr Infect Dis J; 1996 May; 15(5):425-30. PubMed ID: 8724065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of pneumococcal inflammation: otitis media.
    Tuomanen EI
    Vaccine; 2000 Dec; 19 Suppl 1():S38-40. PubMed ID: 11163461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae.
    Daniels CC; Briles TC; Mirza S; Håkansson AP; Briles DE
    Microb Pathog; 2006 May; 40(5):228-33. PubMed ID: 16540281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.